SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CELLULAR BIOMEDICINE GROUP INC
(NQPK:CBMG Last Sale: 14.01 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (CBMG : $14.01)
$271,168 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Palo Alto, CA Research Report Earnings Snapshot - Last
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Research and human treatment experience in progenitor cells and cancer cell technology. Our cellular research and development is the result of collaboration between scientists and doctors from USA and China. CBMG scientists currently develop biomedicine based on tissue-derived progenitor cells, embryonic stem (ES) cells and cancer-specific dendritic cells.
Historical Charts    Technical Analysis
No Historical Data available for CBMG

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CBMG $14.01 $14.01 0 .0 $13.65 $14.3 115,643 $13.65 $14.3 19,355,292
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $271,167,641

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex